Darrin Crisitello joined Quanterix in 2021 as the Chief Commercial Officer with over 20 years of experience leading teams and building businesses. Prior to Quanterix, he was the Chief Commercial Officer at Mission Bio focusing on the Tapestri platform for single-cell multi-omic analysis. Additionally, he has built the commercial teams at both Natera and Color Health, launching various products in the genetic testing field. Darrin is an adjunct partner at IndieBio and advises various invested companies. Darrin received his BS in biology and chemistry from Moravian College and his MBA from the University of Massachusetts.
Demonstrating the clinical utility and cost-effectiveness of innovative blood-based biomarker tests can help pave the way for making timely AD diagnosis and proactive care the norm.